Dr. Shapiro on Preventative Drugs in Breast Cancer

Charles L. Shapiro, MD
Published Online: Monday, Jan 27, 2014

Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses the underutilization of preventative drugs for breast cancer.

Shapiro says preventative drugs in breast cancer are underutilized. There are many people that are considered high-risk for breast cancer but do not choose to take preventative drugs. Many people have a fear of side effects, Shapiro says, and will not take the risk of having side effects if they are not already diagnosed with cancer.

By increasing awareness of preventative drugs for this disease, Shapiro feels that a larger percentage of people who are at a higher risk for breast cancer would take these drugs.

Charles L. Shapiro, MD, professor, College of Medicine, The James, Ohio State University Comprehensive Care Center, discusses the underutilization of preventative drugs for breast cancer.

Shapiro says preventative drugs in breast cancer are underutilized. There are many people that are considered high-risk for breast cancer but do not choose to take preventative drugs. Many people have a fear of side effects, Shapiro says, and will not take the risk of having side effects if they are not already diagnosed with cancer.

By increasing awareness of preventative drugs for this disease, Shapiro feels that a larger percentage of people who are at a higher risk for breast cancer would take these drugs.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 20, 20162.5
Oncology Consultations®: Integrating Molecular Testing into the Breast Cancer Treatment ParadigmSep 28, 20162.0